Editorial: hepatitis B, fatty liver and metabolic syndrome—Interaction or co-existence? Authors’ reply

Yuan Hung Kuo; Sheng Nan Lu

doi:10.1111/apt.15009

Editorial: hepatitis B, fatty liver and metabolic syndrome—Interaction or co-existence? Authors’ reply

Yuan Hung Kuo, Sheng Nan Lu

School of Medicine

Research output: Contribution to journal › Journal Editorial

Original language	English
Pages (from-to)	1162-1163
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	48
Issue number	10
DOIs	https://doi.org/10.1111/apt.15009
State	Published - 11 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/apt.15009

Cite this

@article{e153c2e9fecd479b86ffcf9246a54d78,

title = "Editorial: hepatitis B, fatty liver and metabolic syndrome—Interaction or co-existence? Authors{\textquoteright} reply",

author = "Kuo, {Yuan Hung} and Lu, {Sheng Nan}",

year = "2018",

month = nov,

doi = "10.1111/apt.15009",

language = "英语",

volume = "48",

pages = "1162--1163",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc",

number = "10",

}

TY - JOUR

T1 - Editorial

T2 - hepatitis B, fatty liver and metabolic syndrome—Interaction or co-existence? Authors’ reply

AU - Kuo, Yuan Hung

AU - Lu, Sheng Nan

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85055618201&partnerID=8YFLogxK

U2 - 10.1111/apt.15009

DO - 10.1111/apt.15009

M3 - 社论

C2 - 30375694

AN - SCOPUS:85055618201

SN - 0269-2813

VL - 48

SP - 1162

EP - 1163

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 10

ER -

Editorial: hepatitis B, fatty liver and metabolic syndrome—Interaction or co-existence? Authors’ reply

UN SDGs

Access to Document

Other files and links

Cite this